A chimaeric plant virus vaccine protects mice against a bacterial infection

Microbiology

Volumn 145, Issue 8, 1999, Pages 2061-2067

  Brennan, Frank R ^a   Gilleland, Linda B ^b   Staczek, John ^b   Bendig, Mary M ^a   Hamilton, William D O ^a   Gilleland Jr , Harry E ^b  

^a Axis Genetics plc   (United Kingdom)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Chimaeric virus particle; Cowpea mosaic virus; Outer membrane protein F; Pseudomonas aeruginosa; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; OUTER MEMBRANE PROTEIN; PSEUDOMONAS VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; IMMUNIZATION; LUNG INFECTION; MOSAIC VIRUS; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PLANT VIRUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS PARTICLE;

EID: 0032846470     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-145-8-2061     Document Type: Article

References (38)

1. Abdillahi, H. & Poolman, J. T. (1987). Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48, 367-371.
2. Adams, S. E., Dawson, K. M., Gulli, K., Kingsmart, S. M. & Kingsman, A. J. (1987). The expression of hybrid HIV:ty virus-like particles in yeast. Nature 329, 68-70.
3. Apostolopoulos, V., Pietersz, G. A., Loveland, B. E., Sandrin, M. S. & McKenzie, I. F. C. (1995). Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci USA 92, 10128-10132.
4. Ball, J. M., Hardy, M. E., Atmar, R. L., Conner, M. E. & Estes, M. E. (1998). Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 72, 1345-1353.
5. Brennan, F. R., Bellaby, T., Helliwell, S. M., Jones, T. D., Kamstrup, S., Dalsgaard, K., Flock, J-I. & Hamilton, W. D. O. (1999a). Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J Virol 73, 930-938.
6. Brennan, F. R., Jones, T. D., Gilleland, L. B. & 9 other authors (1999b). Pseudomonas aeruginosa outer membrane protein F epitopes are highly immunogenic when expressed on a plant virus. Microbiology 145, 211-220.
7. Buratti, E., McLain, L., Tisminetzky, S., Cleveland, S. M., Dimmock, N. J. & Baralle, E. (1998). The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against z conformational epitope. J Gen Virol 79, 2709-2716.
8. Buret, A. (1994). Pseudomonas aeruginosa infections in patients with cystic fibrosis, new immunomodulatory strategies. Clin Immunother 2, 261-277.
9. Cripps, A. W., Dunkley, M. L. & Clancy, R. L. (1994). Mucosal and systemic immunization with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect Immun 62, 1427-1436.
10. Dalsgaard, K., Uttenthal, A., Jones, T. D. & 12 other authors (1997). Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 15, 248-252.
11. Deprez, B., Sauzet, J.-P., Boutillon, C., Martinon, F., Tartar, A., Sergheraert, C., Guillet, J.-G., Gomard, E. & Gras-Masse, H. (1996). Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL. Vaccine 14, 375-382.
12. Dunkley, M. L., Cripps, A. W., Reinbott, R. & Clancy, R. L. (1995). Immunity to respiratory P. aeruginosa infection : the role of gut-derived T helper cells and immune serum. In Advances in Mucosal Immunology, pp. 771-775. Edited by J. Mestecky, H. Tlaskalova & J. Steriz. New York: Plenum.
13. Elson, C. O. & Dertzbaugh, M. T. (1994). Mucosal adjuvants. In Handbook of Mucosal Immunology, p. 391-402. Edited by P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee & J. Bienenstock. New York: Academic Press.
14. Everest, P., Griffiths, P. & Dougan, G. (1995). Live Salmonella vaccines as a route towards oral immunization. Biologicals 23, 119-124.
15. Gilleland, L. B. & Gilleland, H. E., Jr (1995). Synthetic peptides representing two protective, linear B cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole cell-reactive antibodies that are functionally pseudomonad-specific. Infect Immun 63, 2347-2351.
16. Gilleland, H. E., Jr, Gilleland, L B. & Matthews-Greer, J. M. (1988). Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun 56, 1017-1022.
17. Gilleland, H. E., Jr, Gilleland, L. B., Hughes, E. E. & Matthews-Greer, J. M. (1992). Recombinant outer membrane protein F of Pseudomonas aeruginosa elicits antibodies that mediate opsonophagocytic killing but not complement-mediated bacteriolysis of various strains of P. aeruginosa. Curr Microbiol 24, 1-7.
18. Gilleland, H. E., Jr, Hughes, E. E., Gilleland, L. B., Matthews-Greer, J. M. & Staczek, J. (1995). Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa. Curr Microbiol 31, 279-286.
19. Gruber, W. C., Campbell, P. W., Thompson, J. M., Reed, G. W., Roberts, B. & Wright, P. F. (1994). Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families : results of a 3-year study. J Infect Dis 169, 241-247.
20. Gupka, R. K. & Siber, G. R. (1995). Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13, 1263-1276.
21. Hughes, E. E. & Gilleland, H. E., Jr (1995). Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa in a murine acute pneumonia model. Vaccine 13, 1750-1753.
22. Hughes, E. E., Gilleland, L. B. & Gilleland, H. E., Jr (1992). Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Infect Immun 60, 3497-3503.
23. Jahn-Schmid, B., Siemann, U., Zenker, A. & 7 other authors (1997). Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12. Int Immunol 9, 1867-1875.
24. Klinman, D. M., Takeno, M., Ichino, M., Gu, M., Yamshchikov, G., Mor, G. & Conover, J. (1997). DNA vaccines : safety and efficacy issues. Springer Semin Immunopathol 19, 245-256.
25. Lovgren, K., Kaberg, H. & Morein, B. (1990). An experimental influenza subunit vaccine (ISCOM) : induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin Exp Immunol 82, 435-440.
26. McLain, L., Porta, C., Lomonossoff, G. P., Durrani, Z. & Dimmock, N. J. (1995). Human immunodeficiency virus type 1 neutralizing antibodies raised to a gp41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retroviruses 11, 327-334.
27. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P., & Dimmock, N. J. (1996). Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14, 799-810.
28. Montgomery, D. L., Donnelly, J. J., Shiver, J. W., Liu, M. A. & Ulmer, J. B. (1994). Protein expression in vivo by injection of polynucleotides. Curr Opin Biotechnol 5, 505-510.
29. Porta, C., Spall, V. E., Loveland, J. E., Johnson, J. E., Barker, P. J. & Lomonossoff, G. P. (1994). Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology 202, 949-955.
30. Reed R. C., Louis-Wileman, V., Cosmai, E. V., Fang, S., Jue, D. L., Wohlhueter, R. M., Hunter, R. L. & Lal, A. A. (1997). Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii. Vaccine 15, 482-488.
31. Resnick, D. A., Smith, A. D., Geisler, S. C., Zhang, A., Arnold, A. & Arnold, G. F. (1995). Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV1) V3 loop seroprevalence library induce neutralizing responses against HIV-1. J Virol 69, 2406-2411.
32. Rose, C. S. P. & Evans, D. J. (1991). Poliovirus antigen chimeras. Trends Biotechnol 9, 415-421.
33. Staczek, J., Gilleland, H. E., Jr, Gilleland, L B., Harty, R. N., Garcia-Sastre, A., Engelhardt, O. G. & Palese, P. (1998). A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomomas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun 66, 3990-3994.
34. Sutter, G. & Moss, B. (1992). Non-replicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci USA 89, 10847-10851.
35. Usha, R., Rohll, J., Spall, V. E., Shanks, M., Maulie, A. J., Johnson, J. E. & Lomonossoff, G. P. (1993). Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 197, 366-374.
36. Vlacha, V., Forman, E. N., Mirond, D. & Peter, G. (1996). Recurrent thrombocytopenic purpura after repeated measles/mumps/rubella vaccination. Pediatrics 97, 738-739.
37. WHO (1990). Potential use of live viral and bacterial vectors for vaccines. WHO meeting, Geneva, 19-22 June, 1989. Vaccine 8, 425-437.
38. Zhang, S., Graebaer, L. A., Helling, F., Ragupathi, G., Adluri, S., Lloyd, K. O. & Livingston, P. O. (1996). Augmenting the imunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res 56, 3315-3319.